Related Experiment Video
Updated: Apr 20, 2026
12:27
A Pipeline to Investigate the Structures and Signaling Pathways of Sphingosine 1-Phosphate Receptors
Published on: June 8, 2022
4.1K
Targeting S1P signaling for drug development.
Yaru Liu1, Yali Song1, Youzhi Wang2
1College of Pharmaceutical Sciences, Key Laboratory of Medicinal Chemistry and Molecular Diagnostics of Education Ministry of China, Key Laboratory of Pharmaceutical Quality Control of Hebei Province, Hebei University, Baoding 071002, China.
Drug Discovery Today
|April 18, 2026
Summary
Sphingosine-1-phosphate (S1P) regulates cell functions and immune cell movement, impacting various diseases. This review covers S1P modulators, their generation, transport, degradation, and structure-activity relationships.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Sphingosine-1-phosphate (S1P) is a key sphingolipid metabolite with diverse biological roles.
- S1P influences cell proliferation, migration, and immune cell trafficking, implicating it in various diseases.
- Current therapeutics include S1P receptor agonists for multiple sclerosis and S1P production inhibitors in cancer trials.
Purpose of the Study:
- To review modulators of Sphingosine-1-phosphate (S1P).
- To discuss the generation, transportation, and degradation of S1P.
- To explore preliminary structure-activity relationships of S1P modulators.
Main Methods:
- Literature review of S1P modulators.
- Analysis of S1P generation, transport, and degradation pathways.
- Examination of structure-activity relationships for S1P modulators.
Main Results:
- Identification of various modulators targeting S1P pathways.
- Understanding of S1P's complex roles in biological processes.
- Preliminary insights into structure-activity relationships guiding drug development.
Conclusions:
- S1P modulators represent a significant therapeutic avenue for multiple sclerosis and cancer.
- Further research into S1P modulators and their structure-activity relationships is warranted.
- Targeting S1P pathways offers potential for treating a wide spectrum of diseases.
More Related Videos
Related Concept Videos
01:27Transducer Mechanism: Enzyme-Linked Receptors
5.1K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
5.1K
01:26Targets for Drug Action: Overview
12.0K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
12.0K
01:28Structure-Activity Relationships and Drug Design
2.2K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.2K
01:29Pharmacogenomics: Identification of New Drug Targets
104
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
104
01:22Amplifying Signals via Enzymatic Cascade
19.7K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
19.7K
01:20The JAK-STAT Signaling Pathway
14.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
14.2K